Comparing the General Anesthesia, the General Anesthesia With the ESP Block or TLIP Block in the Patients Undergoing Lumbar Surgeries

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The regional methods of anesthesia for the neurosurgical operations of the spine and spinal cord reducing the needs for opioids intra operatively and reducing pain in the postoperative period, decrease the numbers of failed back syndrome.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• back surgery

Locations
Other Locations
Ukraine
Anesthesia department Medical Network Dobrobut
RECRUITING
Kyiv
Contact Information
Primary
Yelyzaveta Plechysta, MD
plechysta.y@dobrobut.ua
+380636494490
Time Frame
Start Date: 2022-04-18
Estimated Completion Date: 2025-12-18
Participants
Target number of participants: 450
Treatments
Experimental: General anesthesia
induction: propofol 1.5-2.5 mg\\kg IV bolus and fentanyl 1-2 mcg\\kg maintenance anesthesia: sevoflurane, doses of the inhalation agent according to bispectral index (BIS) monitor ( target BIS level 40-60) and fentanyl 1-5 mcg\\kg\\h.
Experimental: Combined anesthesia: general anesthesia and Erector spinae plane block (ESP block)
induction: propofol 1.5-2.5 mg\kg IV bolus and fentanyl 1-2 mcg\kg ESP- block with US control with single shot of local anesthetic ( bupivacaine 0.375% or 0.25% 20-30 ml) is performed after induction.~maintenance anesthesia: sevoflurane, doses of the inhalation agent according to BIS monitor ( target BIS level 40-60) and fentanyl 0.5-1.5 mcg\kg\h.
Experimental: Combined anesthesia: General anesthesia and Thoraco-lumbar interfacial plane block (TLIP block)
induction: propofol 1.5-2.5 mg\kg IV bolus and fentanyl 1-2 mcg\kg TLIP- block with US control with single shot of local anesthetic ( bupivacaine 0.25% 15 ml or mixed bupivacaine 0.25% 7.5 ml and lidocaine 2% 7.5 ml) is performed after induction.~maintenance anesthesia: sevoflurane, doses of the inhalation agent according to BIS monitor ( target BIS level 40-60) and fentanyl 0.5-1.5 mcg\kg\h.
Related Therapeutic Areas
Sponsors
Leads: Anesthesia Research Group UA

This content was sourced from clinicaltrials.gov

Similar Clinical Trials